FDA approves first generic methimazole tablets for treating hyperthyroidism in cats. Veterinarians can now prescribe a new generic drug to treat hyperthyroidism in cats. The U.S. Food and Drug Administration has approved Methimazole Coated Tablets (ANADA 200-814), the first FDA-approved generic version of methimazole for the treatment of feline hyperthyroidism. Evaluated for bioequivalence to the pioneer drug Felimazole (NADA 141-292), the tablets are reported to have met FDA standards for safety, effectiveness, and manufacturing quality. Available in 2.5 mg and 5 mg strengths for oral administration, the tablets are supplied in 2.5 mg increments every 12 hours, with a maximum daily dose of 20 mg (not exceeding 10 mg per dose). A prescription is required. Veterinarians are advised to monitor patients regularly, as dosing may need adjustment over time due to disease progression. Clients should be instructed to wash their hands after handling the tablets to minimize human exposure. For more information, visit the FDA website.
